• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中性粒细胞与淋巴细胞比值在前列腺癌患者中的临床意义]

[Clinical Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Prostate Cancer].

作者信息

Naito Hirohito, Sugimoto Mikio, Taketa Shigeo, Kakehi Yoshiyuki

机构信息

The Department of Urology, Mizushima Kyodo Hospital.

The Department of Urology, Kagawa University Faculty of Medicine.

出版信息

Hinyokika Kiyo. 2017 Feb;63(2):63-67. doi: 10.14989/ActaUrolJap_63_2_63.

DOI:10.14989/ActaUrolJap_63_2_63
PMID:28264535
Abstract

Neutrophil-to-lymphocyte ratio (NLR), a simple marker of systemic inflammatory response, has clinical and prognostic value in patients with cancer. We evaluated the role of NLR prior to biopsy in patients suspected of having cancer prostate cancer. In this retrospective study, we reviewed the records of 204 patients who underwent prostate biopsy in Mizushima Kyodo Hospital between August 2002 and June 2015 and collected the following data : age, C-reactive protein (CRP), prostate volume (PV), clinical cancer staging, prostate-specific antigen (PSA) prior to biopsy , Gleason score (GS), NLR. NLR was calculated by prebiopsy neutrophil and lymphocyte counts. We divided the 83 of 204 patients found to have prostate cancer (PCa) into two or three groups by the results of biopsy, PSA, clinical cancer staging, GS, and D'Amico risk classification. Mann-Whitney U-test and Kruskal-Wallis H-test were used to compare NLR in each group. Significant differences were recognized in NLR between the groups : PSA≧10 ng/ml VS < 10 ng/ml in all patients and in patients with cancer, cT2b≧ VS cT2c≦, GS 6 VS GS 7 VS GS 8≦ in patients with cancer and low risk VS intermediate risk VS high risk in patients with cancer without metastasis. Also we investigated the correlated factor with NLR in patients with cancer without metastasis. On multiple regression analysis including age, CRP, PV, PSA, clinical tumor stage and GS, PSA and GS had a significant association with NLR.

摘要

中性粒细胞与淋巴细胞比值(NLR)是全身炎症反应的一个简单指标,在癌症患者中具有临床和预后价值。我们评估了NLR在疑似前列腺癌患者活检前的作用。在这项回顾性研究中,我们查阅了2002年8月至2015年6月期间在水岛协同医院接受前列腺活检的204例患者的记录,并收集了以下数据:年龄、C反应蛋白(CRP)、前列腺体积(PV)、临床癌症分期、活检前前列腺特异性抗原(PSA)、 Gleason评分(GS)、NLR。NLR通过活检前中性粒细胞和淋巴细胞计数计算得出。我们根据活检结果、PSA、临床癌症分期、GS和达米科风险分类,将204例被诊断为前列腺癌(PCa)的患者中的83例分为两组或三组。采用Mann-Whitney U检验和Kruskal-Wallis H检验比较各组的NLR。各组之间的NLR存在显著差异:所有患者以及癌症患者中PSA≧10 ng/ml与<10 ng/ml相比,癌症患者中cT2b≧与cT2c≦相比,癌症患者中GS 6与GS 7与GS 8≦相比,无转移癌症患者中低风险与中度风险与高风险相比。我们还研究了无转移癌症患者中与NLR相关的因素。在包括年龄、CRP、PV、PSA、临床肿瘤分期和GS的多元回归分析中,PSA和GS与NLR有显著关联。

相似文献

1
[Clinical Significance of Neutrophil-to-Lymphocyte Ratio in Patients with Prostate Cancer].[中性粒细胞与淋巴细胞比值在前列腺癌患者中的临床意义]
Hinyokika Kiyo. 2017 Feb;63(2):63-67. doi: 10.14989/ActaUrolJap_63_2_63.
2
The values of neutrophil-lymphocyte ratio and/or prostate-specific antigen in discriminating real Gleason score ≥ 7 prostate cancer from group of biopsy-based Gleason score ≤ 6.中性粒细胞-淋巴细胞比值和/或前列腺特异性抗原在鉴别基于活检的 Gleason 评分≤6 与真实 Gleason 评分≥7 前列腺癌中的价值。
BMC Cancer. 2017 Sep 6;17(1):629. doi: 10.1186/s12885-017-3614-9.
3
Neutrophil-to-lymphocyte and neutrophil-to-monocyte rates in the decision for a prostate re-biopsy in patients with a previous benign pathology and consistently 2,5-10 ng/ml PSA value.既往病理结果为良性且前列腺特异性抗原(PSA)值持续在2.5 - 10 ng/ml的患者,在决定是否进行前列腺再次活检时的中性粒细胞与淋巴细胞比率及中性粒细胞与单核细胞比率。
Arch Esp Urol. 2016 Nov;69(9):627-635.
4
Association of the neutrophil-to-lymphocyte ratio and prostate cancer detection rates in patients via contemporary multi-core prostate biopsy.通过当代多芯前列腺活检评估中性粒细胞与淋巴细胞比值与患者前列腺癌检出率的相关性。
Asian J Androl. 2016 Nov-Dec;18(6):937-941. doi: 10.4103/1008-682X.164198.
5
The Change in Neutrophil Lymphocyte Ratio from the First to the Last Repeat Prostate Biopsy Proposed as a Marker of Carcinogenesis.首次与末次重复前列腺活检时中性粒细胞淋巴细胞比值的变化被提议作为致癌作用的标志物。
Urol Int. 2018;101(1):74-79. doi: 10.1159/000489400. Epub 2018 Jun 15.
6
Neutrophil, Platelets, and Eosinophil to Lymphocyte Ratios Predict Gleason Score Upgrading in Low-Risk Prostate Cancer Patients.中性粒细胞、血小板和嗜酸性粒细胞与淋巴细胞比值可预测低风险前列腺癌患者的 Gleason 评分升级情况。
Urol Int. 2019;102(1):43-50. doi: 10.1159/000494259. Epub 2018 Nov 8.
7
Can we use neutrophil to lymphocyte ratio in the diagnosis and prediction of extracapsular extension in localized prostate cancer?我们能否将中性粒细胞与淋巴细胞比值用于局限性前列腺癌包膜外侵犯的诊断和预测?
Urologia. 2022 May;89(2):203-209. doi: 10.1177/03915603211014864. Epub 2021 May 7.
8
Predictive value of neutrophil-to-lymphocyte ratio in diagnosis of early prostate cancer among men who underwent robotic transperineal prostate biopsy.中性粒细胞与淋巴细胞比值对经机器人经会阴前列腺穿刺活检的男性早期前列腺癌的诊断价值。
Medicine (Baltimore). 2021 Dec 17;100(50):e28007. doi: 10.1097/MD.0000000000028007.
9
Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in men undergoing needle biopsy.中性粒细胞与淋巴细胞比值可预测接受穿刺活检男性的前列腺癌。
Oncotarget. 2015 Oct 13;6(31):32169-76. doi: 10.18632/oncotarget.5081.
10
Evaluation of fatty acid synthase in prostate cancer recurrence: SUV of [(11) C]acetate PET as a prognostic marker.脂肪酸合酶在前列腺癌复发中的评估:[(11)C]乙酸PET的SUV作为一种预后标志物
Prostate. 2015 Nov;75(15):1760-7. doi: 10.1002/pros.23061. Epub 2015 Aug 18.

引用本文的文献

1
Validation of the Effectiveness of Neutrophil-to-lymphocyte Ratio (NLR) as a Predictive Factor in Patients Undergoing Prostate Biopsy With Prostate Specific Antigen (PSA) Between 4.0 and 10.0 ng/ml.验证中性粒细胞与淋巴细胞比值(NLR)在前列腺特异性抗原(PSA)在 4.0 至 10.0ng/ml 之间的前列腺活检患者中的预测因子的有效性。
In Vivo. 2021 May-Jun;35(3):1641-1646. doi: 10.21873/invivo.12422.